(Q38005926)

26 August 2017

title

The relationship between lung inflammation and cardiovascular disease (English)

1 reference

26 August 2017

main subject

cardiovascular disease

1 reference

2

Jonathon Leipsic

1 reference

26 August 2017

Stephan Van Eeden

1

1 reference

26 August 2017

S F Paul Man

series ordinal

3

1 reference

26 August 2017

Don D Sin

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

26 April 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

26 August 2017

published in

1 reference

26 August 2017

volume

186

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

11-16

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Increased risk of myocardial infarction and stroke following exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

The lung tissue microbiome in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Long-term ozone exposure and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Long-term exposure to air pollution and incidence of cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Smoke-free legislation and hospitalizations for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Risk of myocardial infarction and stroke after acute infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among Medicare patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Smoking in Relation to Atherosclerosis of the Coronary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Ambient air pollution and the progression of atherosclerosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Ambient air pollution and atherosclerosis in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Particulate air pollution induces progression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Vulnerable plaque: pathobiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Widespread coronary inflammation in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Diagnostic performance of coronary angiography by 64-row CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Cardiovascular events in patients with COPD: TORCH study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0455PP

10.1164/RCCM.201203-0455PP

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference